title: Retreatment with fludarabine and cyclosporine for one case of refractory pure red cell aplasia.
authors.affiliation: Department of Clinical Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Jiangsu Insititute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou 215006. heguangsheng30@yahoo.com.cn
authors.forename: Guang-sheng
authors.initials: GS
authors.lastname: He
authors.forename: Xiang
authors.initials: X
authors.lastname: Zhang
authors.forename: De-pei
authors.initials: DP
authors.lastname: Wu
authors.forename: Ai-ning
authors.initials: AN
authors.lastname: Sun
authors.forename: Miao
authors.initials: M
authors.lastname: Miao
authors.forename: Xiu-li
authors.initials: XL
authors.lastname: Wang
authors.forename: Zheng-ming
authors.initials: ZM
authors.lastname: Jin
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy*; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D014740:Vidarabine; C024352:fludarabine